April 2, 2015

Silence Therapeutics CEO on £40mln fundraise

Ali Mortazavi, the chief executive of Silence Therapeutics (LON:SLN), discusses the £40mln conditional fundraising with Proactive Investors.


He reveals that institutional investors took part in the placing for £27.3mln, which is subject to shareholder approval. The amount raised could rise to £40mln or so if the demand is there, with an option granted to the joint bookrunners to find subscribers for an additional 5.3mln shares.



http://ift.tt/1EL4pxs @MasterMetals MasterMetals Blog

No comments:

Post a Comment

Commented on The MasterMetals BlogThe MasterMetals Blog